Edition:
United States

Karo Pharma AB (KARO.ST)

KARO.ST on Stockholm Stock Exchange

35.65SEK
9:02am EDT
Change (% chg)

0.10kr (+0.28%)
Prev Close
35.55kr
Open
35.40kr
Day's High
36.15kr
Day's Low
35.20kr
Volume
514,426
Avg. Vol
664,822
52-wk High
41.68kr
52-wk Low
25.25kr

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 1 423.00 423.00 423.00 --
Quarter Ending Dec-18 1 473.00 473.00 473.00 --
Year Ending Dec-18 1 1,652.00 1,652.00 1,652.00 --
Year Ending Dec-19 1 2,027.00 2,027.00 2,027.00 --
Earnings (per share)
Quarter Ending Sep-18 1 0.26 0.26 0.26 --
Quarter Ending Dec-18 1 0.25 0.25 0.25 --
Year Ending Dec-18 1 4.81 4.81 4.81 --
Year Ending Dec-19 1 2.08 2.08 2.08 --
Sales and Profit Figures in Swedish Krona (SEK);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 8.86 97.68 30.58
P/E High - Last 5 Yrs. 194.36 268.23 47.03
P/E Low - Last 5 Yrs. 17.52 94.02 24.81
Beta 1.10 0.78 0.85
Price to Sales (TTM) 5.25 260.36 8.15
Price to Book (MRQ) 1.60 12.82 3.78
Price to Tangible Book (MRQ) -- 22.44 5.88
Price to Cash Flow (TTM) 8.98 63.78 21.39
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield 0.79 0.38 1.79
Dividend Yield - 5 Year Avg 0.54 0.22 1.46
Dividend 5 Year Growth Rate -- 2.53 -6.23
Payout Ratio(TTM) 0.00 6.41 46.83

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 243.56 157.03 6.92
Sales (TTM) vs TTM 1 Yr. Ago 144.34 90.80 11.36
Sales - 5 Yr. Growth Rate 81.73 24.32 7.60
EPS (MRQ) vs Qtr. 1 Yr. Ago 1,985.36 89.71 18.25
EPS (TTM) vs TTM 1 Yr. Ago 129.60 -- --
EPS - 5 Yr. Growth Rate -- 23.12 7.55
Capital Spending - 5 Yr. Growth Rate 82.46 36.76 7.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.73 2.53
Current Ratio (MRQ) 0.64 5.48 3.58
LT Debt to Equity (MRQ) 54.47 19.99 11.26
Total Debt to Equity (MRQ) 54.47 23.82 14.56
Interest Coverage (TTM) 3.25 -186.21 31.06

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 56.69 57.78 55.12
Gross Margin - 5 Yr. Avg. -- 52.39 53.21
EBITD Margin (TTM) 32.72 -- --
EBITD - 5 Yr. Avg 2.63 -190.28 15.77
Operating Margin (TTM) 22.88 -1,115.09 -2.60
Operating Margin - 5 Yr. Avg. -4.09 -203.67 10.94
Pre-Tax Margin (TTM) 12.75 -998.61 -0.67
Pre-Tax Margin - 5 Yr. Avg. -10.07 -204.68 11.11
Net Profit Margin (TTM) 48.64 -989.76 -3.89
Net Profit Margin - 5 Yr. Avg. -4.30 -202.39 7.47
Effective Tax Rate (TTM) -281.57 12.19 20.48
Effective Tax Rate - 5 Yr. Avg. -- 18.71 24.17

Efficiency

  Company industry sector
Revenue/Employee (TTM) 14,154,000 5,153,126 735,010,332
Net Income/Employee (TTM) 6,884,463 -5,684,337 85,647,511
Receivable Turnover (TTM) -- 6.46 5.48
Inventory Turnover (TTM) -- 2.30 3.59
Asset Turnover (TTM) 0.26 0.43 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 12.74 2.05 10.23
Return on Assets - 5 Yr. Avg. -1.07 2.59 11.03
Return on Investment (TTM) 15.02 3.30 12.84
Return on Investment - 5 Yr. Avg. -1.46 2.09 14.24
Return on Equity (TTM) 23.35 2.30 15.02
Return on Equity - 5 Yr. Avg. -2.49 -6.83 15.57
  1 Year 3 Year 5 Year
Sales % 89.37 179.68 81.73
EPS (TTM) % -87.84 -- --
Dividend % 13.26 -- --
Note: Units in Millions of US Dollars

Performance for Karo Pharma AB

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 11.79 8.80 99 23
13 Week 37.52 35.84 99 53
26 Week 16.17 7.86 99 55
52 Week -4.97 -10.32 95 82
YTD 12.70 7.91 99 78
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 7.85%
# of Holders: 16
Total Shares Held: 12,906,048
3 Mo. Net Change: 9,132,334
# New Positions: 5
# Closed Positions: 0
# Increased Positions: 10
# Reduced Positions: 4
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.